Production of a bilayered self-assembled skin substitute using a tissue-engineered acellular dermal matrix

Authors: Beaudoin-Cloutier, ChanelGuignard, RinaBernard, GenevièveGauvin, RobertLarouche, DanielleLavoie, AmélieLacroix, DanMoulin, VéroniqueGermain, LucieAuger, François A.
Abstract: Our bilayered self-assembled skin substitutes (SASS) are skin substitutes showing a structure and functionality very similar to native human skin. These constructs are used, in life-threatening burn wounds, as permanent autologous grafts for the treatment of such affected patients even though their production is exacting. We thus intended to shorten their current production time to improve their clinical applicability. A self-assembled decellularized dermal matrix (DM) was used. It allowed the production of an autologous skin substitute from patient's cells. The characterization of SASS reconstructed using a decellularized dermal matrix (SASS-DM) was performed by histology, immunofluorescence, transmission electron microscopy, and uniaxial tensile analysis. Using the SASS-DM, it was possible to reduce the standard production time from about 8 to 4 and a half weeks. The structure, cell differentiation, and mechanical properties of the new skin substitutes were shown to be similar to the SASS. The decellularization process had no influence on the final microstructure and mechanical properties of the DM. This model, by enabling the production of a skin substitute in a shorter time frame without compromising its intrinsic tissue properties, represents a promising addition to the currently available burn and wound treatments.
Document Type: Article de recherche
Issue Date: 28 September 2015
Open Access Date: 2 February 2017
Document version: AM
This document was published in: Tissue engineering. Part C, Methods, Vol. 21 (12), 1297-1305 (2015)
Mary Ann Liebert
Alternative version: 10.1089/ten.TEC.2015.0258
Collection:Articles publiés dans des revues avec comité de lecture

All documents in CorpusUL are protected by Copyright Act of Canada.